Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ORPH | BTAI | LTRN | ||
| Company | Orphazyme A/S ADR | Bioxcel Therapeutics Inc | Lantern Pharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.9060 | 1.1700 | 2.72 | ||
| High | 0.9571 | 1.2300 | 2.72 | ||
| Low | 0.8457 | 1.1500 | 2.51 | ||
| Latest | 0.8700 | 1.1900 | 2.61 | ||
| Change | -0.0200 | +0.0400 | -0.15 | ||
| % Change | -2.25% | +3.48% | -5.43% | ||
| Volume | 941,400 | 373,507 | 113,332 | ||
| 20-Day Average Volume | 1,980,090 | 1,067,166 | 1,640,773 | ||
| Previous Close | 0.8900 | 1.1500 | 2.76 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 0.9128 | 1.1685 | 2.01 | ||
| 20-Day Raw Stochastic | 41.76% | 37.50% | 88.30% | ||
| 20-Day Relative Strength | 36.52 | 43.75 | 56.24 | ||
| Weighted Alpha | -87.89 | -80.40 | -16.36 | ||
| Today's Opinion | 100% Sell | 88% Sell | 56% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 56% Sell | ||
| Last Month's Opinion | 100% Sell | 96% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.47% since 03/23/22 | +13.33% since 04/15/26 | +8.26% since 04/15/26 | ||
| Low | 0.8275 on 03/29/22 | 1.0150 on 04/16/26 | 2.32 on 04/17/26 | ||
| High | 0.9600 on 03/29/22 | 1.2550 on 04/17/26 | 2.82 on 04/21/26 | ||
| 1-Month | |||||
| %Chg | -28.69% since 02/28/22 | -21.19% since 03/20/26 | +23.00% since 03/20/26 | ||
| Low | 0.5101 on 03/14/22 | 1.0100 on 04/14/26 | 1.11 on 03/27/26 | ||
| High | 1.3720 on 03/10/22 | 1.5400 on 03/23/26 | 2.82 on 04/21/26 | ||
| 3-Month | |||||
| %Chg | -67.29% since 12/28/21 | -34.25% since 01/22/26 | -25.78% since 01/22/26 | ||
| Low | 0.5101 on 03/14/22 | 1.0100 on 04/14/26 | 1.11 on 03/27/26 | ||
| High | 2.7500 on 01/03/22 | 1.8700 on 01/26/26 | 3.59 on 01/23/26 | ||
| 6-Month | |||||
| %Chg | -79.33% since 09/28/21 | -46.40% since 10/22/25 | -32.65% since 10/22/25 | ||
| Low | 0.5101 on 03/14/22 | 1.0100 on 04/14/26 | 1.11 on 03/27/26 | ||
| High | 5.4900 on 10/13/21 | 2.4568 on 10/24/25 | 4.28 on 10/27/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 30,721 | 31,136 | 30,163 | ||
| Shares Outstanding, K | 35,312 | 27,075 | 11,255 | ||
| Annual Sales | 0 | 640,000 | 0 | ||
| Annual Net Income | -97,010,000 | -69,900,000 | -17,120,000 | ||
| Last Quarter Sales | N/A | 260,000 | 0 | ||
| Last Quarter Net Income | N/A | -12,550,000 | -4,070,000 | ||
| 60-Month Beta | 1.68 | 0.30 | 1.75 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.58 on 03/27/26 | -0.36 on 03/30/26 | ||
| Latest Earnings Date | 04/05/22 | 05/11/26 | 05/21/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||